Endoscopic therapy for Barrett’s esophagus: our experience beyond white men - ScienceDirect

Gastrointestinal Endoscopy

Volume 82, Issue 2, August 2015, Pages 285-286

Gastrointestinal Endoscopy

https://doi.org/10.1016/j.gie.2015.02.051 Get rights and content

Section snippets

Disclosure

All authors disclosed no financial relationships relevant to this article.

References (8)

R.J. Haidry et al.
Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry
Gastroenterology
(2013)
D.P. Cronin-Fenton et al.
Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis
Eur J Cancer
(2010)
S. Pasricha et al.
Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry
Gastrointest Endosc
(2015)
R. Incarbone et al.
Rising incidence of esophageal adenocarcinoma in Western countries: Is it possible to identify a population at risk?
Dis Esophagus
(2000)

There are more references available in the full text version of this article.

Cited by (1)

Point–Counterpoint: Screening and Surveillance for Barrett’s Esophagus, Is It Worthwhile?
2018, Digestive Diseases and Sciences

Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.